Aspire Capital Fund, LLC is a private, long-only investment fund focused on making investments in US publicly traded biotechnology companies through the open market as well as direct investments including private placements, PIPEs, registered directs, and public offerings. Founded January 1, 2010, Aspire Capital Fund, LLC is managed by Aspire Capital Partners, LLC.
We invest primarily in life sciences companies with bright prospects and strong management teams but whose full potential have not yet been realized in the market. We rely heavily on our ability to conduct rigorous fundamental diligence but we’ve learned that the best returns can only be achieved when incentives are truly aligned. As a result, we work very hard to build strong partnerships with our portfolio company management teams. We firmly believe that we are not just investing in companies; we are investing in relationships.
We start with bottom up analysis and focus on identifying capable, experienced management coupled with robust and well-characterized science. Sounds obvious but we recognize there's immeasurable complexity inherent in creating meaningful technological advances. Therefore, we concentrate our efforts on understanding first principles and investigate opportunities over a series of interactions to not only build our comprehension but importantly, trust, which we acknowledge is a two-way street. Attrition in the development and commercialization of new therapies, tools or devices is inevitable but in our experience, much of the unsystematic risk can be mitigated with trust, good communication, and long term thinking.
At Aspire Capital, we know that when our partner companies do well, we do well. We believe in doing what’s right for everyone involved. Simply stated, we’re invested in your success.
That’s why we go out of our way to be good partners and not just a source of investment. We demand from ourselves a high level of performance and a high level of integrity. We’re fully committed to being a reliable and reasonable investor in publicly traded companies. We believe in long-term, win-win relationships where Aspire Capital’s incentives are aligned with the best interests of our partner companies. It’s only by helping our partner companies succeed that we are rewarded.
Aspire Capital employs a versatile and opportunistic approach to making its long-only equity investments which typically includes one or more of the following transaction types: